MercoPress, en Español
Montevideo, November 20th 2024 - 13:27 UTC
Brazil's National Health Surveillance Agency (Anvisa) has received a request for the emergency use of Pfizer's newest vaccine against COVID-19 which would be active against both the original and the Ômicron strain, subvariant BA.1.
Get our news on your inbox! Suscribe